BioSpace News Archive

Business

vTv Therapeutics and Cantex Pharmaceuticals Announce Strategic Licensing Agreement for Development and Commercialization of Azeliragon for Treatment of Cancer

- vTv Therapeutics Inc. (“vTv”, Nasdaq:VTVT) and Cantex Pharmaceuticals, Inc. (“Cantex”) today announced that they have entered into a licensing agreement under which Cantex has obtained exclusive worldwide rights to develop and commercialize azeliragon, vTv’s novel antagonist of RAGE (the receptor for advanced glycation endproducts).

June 22, 2021
·
4 min read
BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry

BioReference Laboratories, Inc. today announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal Caribbean Group, helping provide a safe environment for travelers.

June 22, 2021
·
4 min read
Business

Small Pharma Engages LifeSci Advisors as Investor Relations Agency

Small Pharma Inc. is pleased to announce that it has retained LifeSci Advisors, LLC to provide investor relations services.

June 22, 2021
·
3 min read
Drug Development

Histogen and Amerimmune Announce Positive Top-Line Study Results from its Phase 1 Study of Emricasan in Mild Symptomatic COVID-19 Patients

Histogen Inc. (NASDAQ: HSTO), and its partner Amerimmune LLC, today announced top line results from its Phase 1 study of emricasan in mild symptomatic COVID-19 patients to assess safety, tolerability, and preliminary efficacy.

June 22, 2021
·
7 min read
FDA

Onkos Surgical Announces FDA 510(k) Clearance of its BioGrip® Modular Porous Collars, a First-of-Its-Kind Solution to Help Address Implant Loosening in Orthopaedic Oncology and Complex Revision Surgery

Onkos Surgical today announced that it has received FDA 510(k) clearance for its modular collar portfolio featuring the Company’s BioGrip® 3D-printed implant technology.

June 22, 2021
·
4 min read
Deals

Avania Acquires IMARC, Global Medical Device CRO

Avania , a leading global medical technology CRO, today announced its acquisition of IMARC, a highly respected medical device CRO headquartered in Strongsville, Ohio and providing service throughout the United States.

June 22, 2021
·
2 min read
Drug Development

Xentria Announces the Initiation of a Clinical Trial for XTMAB-16 for the Treatment of Sarcoidosis

Xentria Inc. today announced that the U.S. Food and Drug Administration (“FDA”) has confirmed that the Company satisfactorily addressed all requirements and can proceed with initiation of the planned Phase 1 clinical trial of XTMAB-16.

June 22, 2021
·
2 min read
Business

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2021

Cyanotech Corporation announced financial results for the fourth quarter and fiscal year 2021, ended March 31, 2021.

June 22, 2021
·
7 min read
Biotech Bay

Guardant Health Expands Guardant360® Portfolio With New Tests for Treatment Response Monitoring and Complete Genomic Profiling

Guardant Health, Inc. (Nasdaq: GH) adds two new products to its portfolio to help improve the management of patients with late-stage and metastatic cancers

June 22, 2021
·
10 min read
FDA

Fist Assist Devices, LLC Announces 510(k) Clearance for Focal Arm Massage and Increased Vein Circulation

Fist Assist Devices, LLC, has received FDA 510(k) clearance for use of the Fist Assist FA-1 device in the United States as an arm massage and increased vein circulation device and has commenced marketing the Fist Assist FA-1 device for that indication for use.

June 22, 2021
·
1 min read